Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferran Algaba

Showing results (31-40 of 131) with videos related to

Pageof 14
Sort By:
Cancer Genetics and Cytogenetics|November 6, 2004
Combination of toluidine blue staining and in situ hybridization to evaluate paraffin tissue sectionsEsther Prat, Jordi Camps, Javier del Rey, et al.
The Journal of Urology|June 18, 2011
Clinical predictive factors of poor outcome in patients with stage pT0 disease at radical cystectomyOscar Rodriguez Faba, Juan Palou, Antonio Rosales, et al.
Urology|July 24, 2014
Juvenile granulosa cell tumor of the testis: a bilateral and synchronous case. Should testis-sparing surgery be mandatory?Marco Cosentino, Ferran Algaba, Lily Saldaña, et al.
Urology|April 14, 2009
Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumorsJuan Palou, Federico Rodríguez-Rubio, Félix Millán, et al.
European Urology|March 30, 2010
Neoadjuvant temsirolimus effectiveness in downstaging advanced non-clear cell renal cell carcinomaOscar Rodríguez Faba, Alberto Breda, Antonio Rosales, et al.
Cancers|March 28, 2026
<i>TFE3</i>-Rearranged and <i>TFEB</i>-Altered Renal Cell Carcinomas: Molecular Landscape and Therapeutic AdvancesMikel Portu, Mario Balsa, Maria Cotaina, et al.
BJU International|February 14, 2006
Prostate carcinoma II: prognostic factors in prostate needle biopsiesRodolfo Montironi, Roberta Mazzucchelli, Marina Scarpelli, et al.
BMC Cancer|June 15, 2010
Centrosome clustering and cyclin D1 gene amplification in double minutes are common events in chromosomal unstable bladder tumorsJavier Del Rey, Esther Prat, Immaculada Ponsa, et al.
European Urology|February 19, 2010
EAU penile cancer guidelines 2009Giorgio Pizzocaro, Ferran Algaba, Simon Horenblas, et al.
European Urology|November 22, 2011
Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-GuérinJoan Palou, Richard J Sylvester, Oscar Rodríguez Faba, et al.
Pageof 14

Showing results (31-40 of 131) with videos related to

Sort By:
Pageof 14
Cancer Genetics and Cytogenetics|November 6, 2004
Combination of toluidine blue staining and in situ hybridization to evaluate paraffin tissue sectionsEsther Prat, Jordi Camps, Javier del Rey, et al.
The Journal of Urology|June 18, 2011
Clinical predictive factors of poor outcome in patients with stage pT0 disease at radical cystectomyOscar Rodriguez Faba, Juan Palou, Antonio Rosales, et al.
Urology|July 24, 2014
Juvenile granulosa cell tumor of the testis: a bilateral and synchronous case. Should testis-sparing surgery be mandatory?Marco Cosentino, Ferran Algaba, Lily Saldaña, et al.
Urology|April 14, 2009
Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumorsJuan Palou, Federico Rodríguez-Rubio, Félix Millán, et al.
European Urology|March 30, 2010
Neoadjuvant temsirolimus effectiveness in downstaging advanced non-clear cell renal cell carcinomaOscar Rodríguez Faba, Alberto Breda, Antonio Rosales, et al.
Cancers|March 28, 2026
<i>TFE3</i>-Rearranged and <i>TFEB</i>-Altered Renal Cell Carcinomas: Molecular Landscape and Therapeutic AdvancesMikel Portu, Mario Balsa, Maria Cotaina, et al.
BJU International|February 14, 2006
Prostate carcinoma II: prognostic factors in prostate needle biopsiesRodolfo Montironi, Roberta Mazzucchelli, Marina Scarpelli, et al.
BMC Cancer|June 15, 2010
Centrosome clustering and cyclin D1 gene amplification in double minutes are common events in chromosomal unstable bladder tumorsJavier Del Rey, Esther Prat, Immaculada Ponsa, et al.
European Urology|February 19, 2010
EAU penile cancer guidelines 2009Giorgio Pizzocaro, Ferran Algaba, Simon Horenblas, et al.
European Urology|November 22, 2011
Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-GuérinJoan Palou, Richard J Sylvester, Oscar Rodríguez Faba, et al.
Pageof 14